Literature DB >> 28069100

Detection of Piperacillin-Tazobactam-Resistant/Pan-β-Lactam-Susceptible Escherichia coli with Current Automated Susceptibility Test Systems.

Marguerite L Monogue1, Linda K Tanner2, Stephen M Brecher3, Jaber Aslanzadeh4, David P Nicolau1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28069100     DOI： 10.1017/ice.2016.325

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


× No keyword cloud information.
  3 in total

1.  Epidemiology of Bloodstream Infections Caused by Escherichia coli and Klebsiella pneumoniae That Are Piperacillin-Tazobactam-Nonsusceptible but Ceftriaxone-Susceptible.

Authors:  Thomas M Baker; Wesley Rogers; Kalyan D Chavda; Lars F Westblade; Stephen G Jenkins; David P Nicolau; Barry N Kreiswirth; David P Calfee; Michael J Satlin
Journal:  Open Forum Infect Dis       Date:  2018-11-19       Impact factor: 3.835

2.  Bloodstream Infection due to Piperacillin/Tazobactam Non-Susceptible, Cephalosporin-Susceptible Escherichia coli: A Missed Opportunity for De-Escalation of Therapy.

Authors:  Leah Carlisle; Julie Ann Justo; Majdi N Al-Hasan
Journal:  Antibiotics (Basel)       Date:  2018-12-01

3.  Ultrasensitive and rapid identification of ESRI developer- and piperacillin/tazobactam-resistant Escherichia coli by the MALDIpiptaz test.

Authors:  Angel Rodríguez Villodres; Lydia Gálvez Benítez; Manuel J Arroyo; Gema Méndez; Luis Mancera; Andrea Vila Domínguez; José Antonio Lepe Jímenez; Younes Smani
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 19.568
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.